Clinical Trial

Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia(AOBA Study)

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This trial will evaluate the efficacy of KK8398 on annualized height velocity after 52 weeks of repeated administration of KK8398 to patients with achondroplasia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-07.
Trial Details
NCT Number NCT06926491
Lead Sponsor Kyowa Kirin Co., Ltd.
Conditions Achondroplasia
Enrollment 6 participants
Start Date 2024-12-01
Primary Completion 2029-05-31 (estimated)
Study Completion 2031-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-29